Caroline Helwick[email protected]MRIBreast MRI pinpoints residual disease after chemotherapyBreast MRI accurately reflects the pathologic extent of residual disease following neoadjuvant chemotherapy, and tumor size and contrast kinetics measured by MRI may be useful early predictors of treatment response, according to a study presented at the San Antonio Breast Cancer Symposium.December 18, 2008Page 1 of 1Top StoriesBreastDBT may increase radiation exposure for women with breast implantsIncluding nonimplant-displaced views on DBT can lead to overall increased average glandular dosage for women with augmented breasts.InterventionalARRS: MWA safe, effective method to treat bone metastasesArtificial IntelligenceACR responds to Congressional query on AI reimbursementISMRM 2024ISMRM: MRI useful in predicting tumor response in breast cancer patientsSponsor ContentIMV’s Oncology in Diagnostic Imaging Market Outlook Report